APUS Stock Analysis: Buy, Sell, or Hold?
APUS - Apimeds Pharmaceuticals US, Inc.
$0.89
-0.05 (-5.82%)
▼
5d:
-33.58%
30d:
-36.43%
90d:
-35.96%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: May 25, 2026
0d
Get Alerted When APUS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: APUS is down 33.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: APUS is down 33.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: APUS is currently trading at $0.89, which is considered oversold relative to its 30-day fair value range of $1.17 to $1.47.
Technical Outlook: Technically, APUS is in a downtrend. Immediate support is located at $0.85, while resistance sits at $1.55. Short-term momentum is weak, with the stock down 5.8% recently.
Market Sentiment: APUS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, APUS is in a downtrend. Immediate support is located at $0.85, while resistance sits at $1.55. Short-term momentum is weak, with the stock down 5.8% recently.
Market Sentiment: APUS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.17 -
$1.47
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
88.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.8%)
- WARNING: Recommendation downgraded due to -33.6% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.17 -
$1.47
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.85
Resistance Level
$1.55
Current Trend
Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Share & Embed Analysis
Last updated: June 23, 2026 4:14 PM ET
Data refreshes hourly during market hours. Next update: 5:14 PM
Data refreshes hourly during market hours. Next update: 5:14 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APUS showing a specific setup today?
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 60 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 64 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 67 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 58 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 57 HOLD |